Protagonist Therapeutics (PTGX)

• Market cap: $4.89B
• 1 day: 0.99%
• 5 days: 4.65%
• 1 month: 18.35%
• 3 months: 45.97%
• 6 months: 71.58%
• Year to date: 101.69%
• 1 year: 71.51%
• 5 years: 303.18%
• 10 years: 571.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 130